NanoSyrinx
Developer of a novel biologics drug research platform designed to serve the biopharmaceutical sector. The company leverages a synthetic biology approach to create a completely novel method for targete...
Valuation
$27.4M
Latest known
Share Price
N/A
Total Raised
$20.1M
Last Round
N/A